Ann: VIRALEZE distribution in Saudi Arabia - supplementary info, page-41

Appreciate your thoughtful comments. it took company long time to get viraleze and Bv deals which suggests partners are not impressed with technology or Commercial offering is not appealing or management not capable. . Either way to cancel and reissue deals would require new partners and the failure of current deals will devalue asset.

I expect none of the 3 vivagel products have even covered costs. one time could be explain by bad circumstance but 3 time just looks like bad management. I thinks this management team been in job too long and not achieving but very well paid for not deliver value. Shake up needed to review commercial value and stop covering up mistakes. .